Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966562248> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W1966562248 endingPage "135" @default.
- W1966562248 startingPage "131" @default.
- W1966562248 abstract "The course of essential thrombocythemia (ET) is complicated by bleeding, major thrombosis, and microvascular complications. Because about one-half of ET patients remain asymptomatic long term, the decision to use aspirin acetylsalicylic acid, (ASA) or myelotoxic drugs has not yet been clearly established. While vasomotor symptoms are improved by small doses of ASA, higher doses (900 mg/day) induce an unacceptable rate of serious hemorrhagic complications in patients with polycythemia vera. This retrospective study evaluates the utility of therapy in preventing thrombosis in ET and the efficacy and a safety of 100 mg/day of ASA in these patients. One hundred ninety-five consecutive patients with ET diagnosed in agreement with the Polycythemia Vera Study Group (PVSG) criteria are evaluated. All vascular complication before, at, or after diagnosis were recorded and related to the treatment used: no therapy, ASA alone, myelosuppressive agents or both. All treated patients had a significant reduction of thrombotic complications without increased hemorrhagic complications, in spite of therapy adopted. In addition, a significant reduction of rethrombosis was obtained in 60 patients with a previous thrombosis. A low rate of thrombosis (5.1%) was observed during the follow-up of the 135 patients previously asymptomatic for major complications. No difference appears to exist between the use of ASA and cytotoxic drugs in preventing thrombosis and rethrombosis in ET patients. However, the possible increase of cancer and leukemia with myelosuppressive drugs is minimized in patients treated with ASA. A low dose of ASA would seem to be a safe and effective agent in ET." @default.
- W1966562248 created "2016-06-24" @default.
- W1966562248 creator A5032001263 @default.
- W1966562248 creator A5046215401 @default.
- W1966562248 creator A5046561459 @default.
- W1966562248 creator A5047421266 @default.
- W1966562248 creator A5083081146 @default.
- W1966562248 date "1999-04-01" @default.
- W1966562248 modified "2023-10-10" @default.
- W1966562248 title "State-of-the-Art Review : Aspirin Seems as Effective as Myelosuppressive Agents in the Prevention of Rethrombosis in Essential Thrombocythemia" @default.
- W1966562248 cites W1964425779 @default.
- W1966562248 cites W1998325169 @default.
- W1966562248 cites W2014136484 @default.
- W1966562248 cites W2019554873 @default.
- W1966562248 cites W2052905336 @default.
- W1966562248 cites W2076914763 @default.
- W1966562248 cites W2111077121 @default.
- W1966562248 cites W2117054170 @default.
- W1966562248 cites W2134004558 @default.
- W1966562248 cites W2229971338 @default.
- W1966562248 cites W2320032845 @default.
- W1966562248 cites W2385547 @default.
- W1966562248 cites W3016233686 @default.
- W1966562248 cites W4235459854 @default.
- W1966562248 cites W4239471829 @default.
- W1966562248 cites W45813627 @default.
- W1966562248 doi "https://doi.org/10.1177/107602969900500210" @default.
- W1966562248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10725994" @default.
- W1966562248 hasPublicationYear "1999" @default.
- W1966562248 type Work @default.
- W1966562248 sameAs 1966562248 @default.
- W1966562248 citedByCount "23" @default.
- W1966562248 countsByYear W19665622482013 @default.
- W1966562248 countsByYear W19665622482014 @default.
- W1966562248 countsByYear W19665622482017 @default.
- W1966562248 crossrefType "journal-article" @default.
- W1966562248 hasAuthorship W1966562248A5032001263 @default.
- W1966562248 hasAuthorship W1966562248A5046215401 @default.
- W1966562248 hasAuthorship W1966562248A5046561459 @default.
- W1966562248 hasAuthorship W1966562248A5047421266 @default.
- W1966562248 hasAuthorship W1966562248A5083081146 @default.
- W1966562248 hasConcept C126322002 @default.
- W1966562248 hasConcept C141071460 @default.
- W1966562248 hasConcept C2777628954 @default.
- W1966562248 hasConcept C2777910003 @default.
- W1966562248 hasConcept C2778837598 @default.
- W1966562248 hasConcept C2780868729 @default.
- W1966562248 hasConcept C2781362458 @default.
- W1966562248 hasConcept C71924100 @default.
- W1966562248 hasConcept C81182388 @default.
- W1966562248 hasConcept C90924648 @default.
- W1966562248 hasConceptScore W1966562248C126322002 @default.
- W1966562248 hasConceptScore W1966562248C141071460 @default.
- W1966562248 hasConceptScore W1966562248C2777628954 @default.
- W1966562248 hasConceptScore W1966562248C2777910003 @default.
- W1966562248 hasConceptScore W1966562248C2778837598 @default.
- W1966562248 hasConceptScore W1966562248C2780868729 @default.
- W1966562248 hasConceptScore W1966562248C2781362458 @default.
- W1966562248 hasConceptScore W1966562248C71924100 @default.
- W1966562248 hasConceptScore W1966562248C81182388 @default.
- W1966562248 hasConceptScore W1966562248C90924648 @default.
- W1966562248 hasIssue "2" @default.
- W1966562248 hasLocation W19665622481 @default.
- W1966562248 hasLocation W19665622482 @default.
- W1966562248 hasOpenAccess W1966562248 @default.
- W1966562248 hasPrimaryLocation W19665622481 @default.
- W1966562248 hasRelatedWork W124733979 @default.
- W1966562248 hasRelatedWork W1506391849 @default.
- W1966562248 hasRelatedWork W1889629264 @default.
- W1966562248 hasRelatedWork W2083469408 @default.
- W1966562248 hasRelatedWork W2143014395 @default.
- W1966562248 hasRelatedWork W2349524821 @default.
- W1966562248 hasRelatedWork W2377532759 @default.
- W1966562248 hasRelatedWork W2391300479 @default.
- W1966562248 hasRelatedWork W2409651431 @default.
- W1966562248 hasRelatedWork W1650630163 @default.
- W1966562248 hasVolume "5" @default.
- W1966562248 isParatext "false" @default.
- W1966562248 isRetracted "false" @default.
- W1966562248 magId "1966562248" @default.
- W1966562248 workType "article" @default.